Engineered VPg saRNA achieves cap-independent, low-immunogenic and precise encoding of therapeutic proteins in vivo
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Researchers have engineered a type of saRNA called VPg that can encode therapeutic proteins in a living organism. This engineered VPg saRNA is said to have several desirable properties, including cap-independent and low-immunogenic encoding. It is reported to achieve precise encoding of therapeutic proteins in vivo.